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Healthy Vision Month — May 2019
May is Healthy Vision Month, an annual observance 
dedicated to making vision and eye health a national 
priority. During this month, CDC’s Vision Health 
Initiative (VHI) in the Division of Diabetes Translation 
joins with the National Eye Institute’s National Eye Health 
Education Program to educate the public about preventing 
vision loss and promoting eye health. Almost 3.22 million 
U.S. persons are affected by vision impairment, which can 
be associated with social isolation, disability, and decreased 
quality of life (https://www.cdc.gov/visionhealth/risk/
burden.htm).
In this issue of MMWR, VHI staff members report find-
ings from their study examining the association of vision 
impairment and functional limitations related to subjec-
tive cognitive decline (SCD), defined as the experience of 
worsening or more frequent confusion or memory loss (1). 
Analysis of data from the Behavioral Risk Factor Surveillance 
System survey for the years 2015–2017 indicated that 
persons with vision impairment were 3.5 times more likely 
to report functional limitations related to SCD than were 
those with no vision impairment.
With the number of U.S. adults with vision impairment 
projected to double in the next 30 years (2), understanding 
the impact of comorbid vision and SCD on functioning is 
just one of many important public health concerns related 
to vision loss. For information on topics related to vision and 
eye health, including common eye disorders, prevention, 
and related state and community programs, please visit the 
VHI web page (https://www.cdc.gov/visionhealth).
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Vision impairment affects approximately 3.22 million 
persons in the United States and is associated with social iso-
lation, disability, and decreased quality of life (1). Cognitive 
decline is more common in adults with vision impairment 
(2,3). Subjective cognitive decline (SCD), which is the self-
reported experience of worsening or more frequent confusion 
or memory loss within the past 12 months, affects 11.2% of 
adults aged ≥45 years in the United States (4). One conse-
quence of SCD is the occurrence of functional limitations, 
especially those related to usual daily activities; however, it is 
not known whether persons with vision impairment are more 
likely to have functional limitations related to SCD (4). This 
report describes the association of vision impairment and 
SCD-related functional limitations using Behavioral Risk 
Factor Surveillance System (BRFSS) surveys for the years 
2015–2017. Adjusting for age group, sex, race/ethnicity, 
